These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3523138)

  • 1. Cytotoxicity assays based on the use of antibody secretion as a measure of hybridoma viability.
    Marbrook J
    Methods Enzymol; 1986; 121():759-71. PubMed ID: 3523138
    [No Abstract]   [Full Text] [Related]  

  • 2. The haemolytic plaque reduction technique to measure cytotoxicity with hybridoma cells as a target.
    Ezaki T; Marbrook J
    J Immunol Methods; 1982 Nov; 54(3):281-90. PubMed ID: 6757326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal cytotoxic T lymphocyte hybridomas capable of specific killing activity, antigenic responsiveness, and inducible interleukin secretion.
    Kaufmann Y; Berke G
    J Immunol; 1983 Jul; 131(1):50-6. PubMed ID: 6190926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of anti-T3-bearing murine hybridoma cells by human allospecific cytotoxic T cell clones and inhibition of that lysis by anti-T3 and anti-LFA-1 antibodies.
    Hoffman RW; Bluestone JA; Leo O; Shaw S
    J Immunol; 1985 Jul; 135(1):5-8. PubMed ID: 2582047
    [No Abstract]   [Full Text] [Related]  

  • 5. Culture conditions that optimize outgrowth of hybridomas.
    Hamilton MJ; Davis WC
    Methods Mol Biol; 1995; 45():17-28. PubMed ID: 7550679
    [No Abstract]   [Full Text] [Related]  

  • 6. The adaptation of the plaque reduction assay for measuring specific cytotoxic cells in limiting dilution cultures.
    Ezaki T; Christensen ND; Skinner MA; Marbrook J
    J Immunol Methods; 1984 Feb; 66(2):357-68. PubMed ID: 6418824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T cell hybridomas: generation and characterization.
    Eshhar Z; Waks T; Oren T; Berke G; Kaufmann Y
    Curr Top Microbiol Immunol; 1982; 100():11-8. PubMed ID: 6980088
    [No Abstract]   [Full Text] [Related]  

  • 8. A dual-chamber system for screening cytotoxic effects of hybridoma-produced antibodies.
    Long TT; Kalantarov G; Chudner A; Trakht I
    Monoclon Antib Immunodiagn Immunother; 2013 Aug; 32(4):246-54. PubMed ID: 23909417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of hybrid hybridomas to target human cytotoxic T lymphocytes.
    Lanzavecchia A; Scheidegger D
    Eur J Immunol; 1987 Jan; 17(1):105-11. PubMed ID: 3102250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybridomas producing hemolytic plaques used to study the relationship between monoclonal antibody affinity and the efficiency of plaque inhibition with increasing concentrations of antigen.
    Bankert RB; Mazzaferro D; Mayers GL
    Hybridoma; 1981; 1(1):47-58. PubMed ID: 6765319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell growth supplements for promoting the growth of monoclonal antibody-producing hybridoma cells.
    Ransom JH
    Methods Enzymol; 1986; 121():293-5. PubMed ID: 3724467
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of multicycle influenza virus replication by hybrid antibody-directed cytotoxic T lymphocyte lysis.
    Moran TM; Usuba O; Kuzu H; Kuzu Y; Schulman J; Bona CA
    J Immunol; 1991 Jan; 146(1):321-6. PubMed ID: 1824592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-T3 antibody both activates and inhibits the cytotoxic activity of human T cell clones.
    Hoffman RW; Quinones RR; Shaw S
    Behring Inst Mitt; 1985 Aug; (77):30-8. PubMed ID: 3936472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific monoclonal antibodies.
    DeMonte LB; Nistico P; Tecce R; Dellabona P; Momo M; Anichini A; Mariani M; Natali PG; Malavasi F
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2941-5. PubMed ID: 2326256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of specific anti-hapten antibody-producing hybridoma cells in tissue sections of spleen and liver by hapten-enzyme conjugates using an immunoenzyme approach.
    Boorsma DM; Claassen E; Kors N; De Haan P; Van Rooijen N
    Hybridoma; 1986; 5(4):347-51. PubMed ID: 3804360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a subset of bovine T lymphocytes that express BoT4 by monoclonal antibodies and function: similarity to lymphocytes defined by human T4 and murine L3T4.
    Baldwin CL; Teale AJ; Naessens JG; Goddeeris BM; MacHugh ND; Morrison WI
    J Immunol; 1986 Jun; 136(12):4385-91. PubMed ID: 2423591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth of hybridoma cells and antibody production in agamma calf serum.
    Torres AR; Healey MC; Johnston AV; McKnight ME
    Hum Antibodies Hybridomas; 1992 Oct; 3(4):206-11. PubMed ID: 1477302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth requirements of T cell hybridomas obtained by the fusion between a mouse cytolytic T cell line and the rat tumor C58NTD.
    Silva A; Fernandez-Ruiz E; Sanz E; Somoza C
    Hybridoma; 1989 Feb; 8(1):61-71. PubMed ID: 2784405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitated cell fusion for hybridoma production.
    Conrad MK; Lo MM
    Methods Enzymol; 1990; 184():641-53. PubMed ID: 2167431
    [No Abstract]   [Full Text] [Related]  

  • 20. Production of monoclonal antibodies by agarose-entrapped hybridoma cells.
    Nilsson K; Scheirer W; Katinger HW; Mosbach K
    Methods Enzymol; 1986; 121():352-60. PubMed ID: 3724475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.